Cite
Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
MLA
Zumla, Alimuddin, et al. “Emerging Novel and Antimicrobial-Resistant Respiratory Tract Infections: New Drug Development and Therapeutic Options.” Lancet Infectious Diseases, vol. 14, no. 11, Nov. 2014, pp. 1136–49. EBSCOhost, https://doi.org/10.1016/S1473-3099(14)70828-X.
APA
Zumla, A., Memish, Z. A., Maeurer, M., Bates, M., Mwaba, P., Al-Tawfiq, J. A., Denning, D. W., Hayden, F. G., & Hui, D. S. (2014). Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infectious Diseases, 14(11), 1136–1149. https://doi.org/10.1016/S1473-3099(14)70828-X
Chicago
Zumla, Alimuddin, Ziad A Memish, Markus Maeurer, Matthew Bates, Peter Mwaba, Jaffar A Al-Tawfiq, David W Denning, Frederick G Hayden, and David S Hui. 2014. “Emerging Novel and Antimicrobial-Resistant Respiratory Tract Infections: New Drug Development and Therapeutic Options.” Lancet Infectious Diseases 14 (11): 1136–49. doi:10.1016/S1473-3099(14)70828-X.